Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Infectious Diseases|October 27, 2012
Cooling off the host immune response to acute simian immunodeficiency virus infection--is less more?Nelson L Michael
Nature Medicine|August 2, 2002
Host genetics and HIV--removing the maskNelson L Michael
The New England Journal of Medicine|November 25, 2010
Oral preexposure prophylaxis for HIV--another arrow in the quiver?Nelson L Michael
Science Translational Medicine|December 8, 2017
Clinical trial design: The nobility of randomizationNelson L Michael
The Journal of Clinical Investigation|October 1, 2019
Simplified steps to heterologous prime-boost HIV vaccine development?Nelson L Michael
The Journal of Clinical Investigation|December 29, 2011
Rare serotype adenoviral vectors for HIV vaccine developmentNelson L Michael
The New England Journal of Medicine|November 11, 2020
SARS-CoV-2 in the U.S. Military - Lessons for Civil SocietyNelson L Michael
Expert Opinion on Biological Therapy|May 16, 2012
Improved outlook on HIV-1 prevention and vaccine developmentSandhya Vasan, Nelson L Michael
Cell|November 24, 2014
Accelerating HIV-1 Vaccine Efficacy TrialsDan H Barouch, Nelson L Michael
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2005
PCR amplification, cloning, and construction of HIV-1 infectious molecular clones from virtually full-length HIV-1 genomesPhilip K Ehrenberg, Nelson L Michael
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Infectious Diseases|October 27, 2012
Cooling off the host immune response to acute simian immunodeficiency virus infection--is less more?Nelson L Michael
Nature Medicine|August 2, 2002
Host genetics and HIV--removing the maskNelson L Michael
The New England Journal of Medicine|November 25, 2010
Oral preexposure prophylaxis for HIV--another arrow in the quiver?Nelson L Michael
Science Translational Medicine|December 8, 2017
Clinical trial design: The nobility of randomizationNelson L Michael
The Journal of Clinical Investigation|October 1, 2019
Simplified steps to heterologous prime-boost HIV vaccine development?Nelson L Michael
The Journal of Clinical Investigation|December 29, 2011
Rare serotype adenoviral vectors for HIV vaccine developmentNelson L Michael
The New England Journal of Medicine|November 11, 2020
SARS-CoV-2 in the U.S. Military - Lessons for Civil SocietyNelson L Michael
Expert Opinion on Biological Therapy|May 16, 2012
Improved outlook on HIV-1 prevention and vaccine developmentSandhya Vasan, Nelson L Michael
Cell|November 24, 2014
Accelerating HIV-1 Vaccine Efficacy TrialsDan H Barouch, Nelson L Michael
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2005
PCR amplification, cloning, and construction of HIV-1 infectious molecular clones from virtually full-length HIV-1 genomesPhilip K Ehrenberg, Nelson L Michael
Pageof 39